Combining carboplatin, a common chemotherapy drug, with everolimus, a drug that blocks mTOR, is effective at inducing apoptosis and slowing tumor growth in patients with pediatric low-grade glioma brain cancer.
The release and uptake of dopamine and serotonin becomes sluggish in rat brains following chemotherapy, researchers report.
